CMB International Securities  Equity Research  Company Update
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
China FB Sector
Mkt Cap (HK mn)
Avg 3 mths to (HK mn)
52w HighLow (HK)
Total Issued Shares (mn)
Source Bloomberg
Shareholding Structure
Source HKEx
Source Bloomberg
12-mth Price Performance
Source Bloomberg
Auditor Da Hua
Yili  Expect full recovery of sales
by Jun  4 May 2020
China Dairy Sector  - Multiple
consolidation to continue  19 Nov
BUY (Maintain)
(Previous TP
UpDownside
2Q20 NP 72% YoY strongly beat expectation on better GPM and selling
expenses ratio  FY20E adj NP growth is on track to meet share award scheme
requirement We raised FY20-22E NP by 7-13% and lifted TP from RMB3310 to
RMB4590 based on 32x FY21E PE (vs 28x avg FY20E and 21E EPS
previously) which is the avg of mid-point (28x) and peak (32x) 1-yr forward PE
range since A-share was announced to be included in MSCI Emerging Markets
Index on 21 Jun 2017  FY19-22E EPS CAGR is improved from 10% to 13% We
expect Yili would continue to benefit from industry consolidation Maintain Buy
 2Q20 results strongly beat on better margins 1H20 NP fell 1% to
RMB3781mn (equivalent to 60% of our FY20E NP est vs 54-56% in 1H17-
1H19) 2Q20 NP jumped 72% Revenue rose 22% led by liquid milk (17%)
and milk powder (86%) By key products Satine rose 25% (vs Milk Deluxe
30%) and Pro-Kido rose 40% Ambrosial rose 10% in 2Q20 but still fell 5%
in 1H20 as consumption pattern shifted from yogurt to milk 2Q20 GPM
widened 16ppt to 387% on reduced promotions and better product mix NP
jumped 72% on operating leverage and GPM expansion
 Grabbed more market share According to Nielsen data retail sales of
ambient liquid milk and chilled liquid milk decreased by 51% and 78%
respectively while retail sales of IMF increased by 49% in 1H20 Organic
liquid milk chilled fresh milk and UHT milk outperformed the market by
growing 126% 123% and 75% respectively in terms of retail sales During
the period Yilis market share of ambient productschilled products increased
by 3203ppt to 388%153% but market share of IMF fell 02ppt to 58%
 2H20E outlook Yili maintained its 2020 target of RMB97bn total revenue (8%
YoY) 1H20 adj NP growth was 146% (on share award scheme benchmark)
on track to meet 10% growth target in FY20E Though raw milk cost is
expected to increase in 2H20E Yili expects this trend would limit industrys
promotion activities in 2H For selling expenses ratio Yili expects a slight YoY
decline trend on precise spending
 New businesses development (1) Chilled fresh milk Current market size
is RMB10bn Yili recorded around RMB300mn sales in 1H20 Sector growth
depends on ongoing consumer education and cold chain development
Management expects ambient milk remains the key growth driver (2) Cheese
Market size of B2C is around RMB3bn and B2Bs size could be 2-3x of B2C
Yili recorded RMB200m sales in 1H20 (vs MNs RMB457mn)
 Maintain Buy We lifted FY202122E NP by 13%7%9% to mainly factor in
lower selling expenses ratio Catalysts better-than-expected revenue and
margins Risks Raw milk cost pressure food safety issues
(YE 31 Dec)
Revenue (RMB mn)
YoY growth (%)
Net profit (RMB mn)
YoY growth (%)
Consensus EPS (RMB)
Source Company data Bloomberg CMBIS estimates
Yili (600887 CH)
2Q20 strongly beat TP lifted to RMB4590
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Figure 1 1H20 results review
Source Company CMBIS
YE Dec (RMB mn)
Sales of key products Satine Ambrosial Changqing
Pro-Kido Chocliz and others grew by 4%
Selling and distribution expenses
AP exp 2%
Administrative expenses
driven by share award exp
RD expenses
Tax  surcharges
Other gains(losses)
donation exp increased by RMB276mn
Share of profit from JVassociate
borrowings jumped due to high capex plan
Non-controlling interests
Margin  Ratio (%)
Selling expenses expenses ratio
Administrateive expenses ratio
RD expenses ratio
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Figure 2 Earnings revision
Source Company data CMBIS estimates
Figure 3 CMBIS estimates vs consensus
Source Bloomberg CMBIS estimates
Figure 4 PE band chart
Source CMBIS estimates Bloomberg Company data
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
YE 31 Dec (RMB mn)
FY18A FY19A FY20E FY21E FY22E  YE 31 Dec (RMB mn)
FY18A FY19A FY20E FY21E FY22E
97286 108915 119932  Profit before tax
95409  JV  associates
16308  DA
1198  Change in working capital
45721  Operating cash flow
1034  Capex
(19773) (21070) (22473) (25159) (27704)  Acquisitions
(5637)  Others
(1853)  Investing cash flow
18  Dividend and interest paid
Other gains(losses)
(86)  Others
JV  associates
446  Financing cash flow
Pre-tax profit
(1793)  Net change in cash
Less Minority interests
(20)  Cash at the beginning
10124  Exchange difference
YE 31 Dec (RMB mn)
FY18A FY19A FY20E FY21E FY22E  YE 31 Dec
FY18A FY19A FY20E FY21E FY22E
Non-current assets
Prepaid lease payments
3073   Ice-cream
Other non-current assets
Current ratio (x)
Quick ratio (x)
AC receivables days
AC payables days
Net cash (RMB mn)
Non-current liabilities
5255  Returns (%)
Shareholders equity
Non-controlling interests
BVPS (RMB)
Source Company data CMBIS estimates
PLEASE READ THE ANALYST CERTIFICATION AND IMPORTANT DISCLOSURES ON LAST PAGE
Disclosures  Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report in whole or in part certifies that with respect to the securities
or issuer that the analyst covered in this report (1) all of the views expressed accurately reflect his or her personal views about the subject securities
in this report
Besides the analyst confirms that neither the analyst nor hisher associates (as defined in the code of conduct issued by The Hong Kong Securities
and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue
of this report (2) will deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report (3) serve
covered in this report
 Stock with potential return of over 15% over next 12 months
 Stock with potential return of 15% to -10% over next 12 months
 Stock with potential loss of over 10% over next 12 months
 Stock is not rated by CMBIS
OUTPERFORM                     Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM             Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM                 Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Securities Limited
Address 45F Champion Tower 3 Garden Road Hong Kong Tel (852) 3900 0888   Fax (852) 3900 0800
CMB International Securities Limited (CMBIS) is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned subsidiary
of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities  The information contained in this report may not be suitable for the purposes of all investors
CMBIS does not provide individually tailored investment advice This report has been prepared without regard to the individual investment objectives
financial position or special requirements  Past performance has no indication of future performance and actual events may differ materially from
that which is contained in the report  The value of and returns from any investments are uncertain and are not guaranteed and may fluctuate as a
independently evaluate particular investments and strategies and encourages investors to consult with a professional financial advisor in order to
make their own investment decisions
This report or any information contained herein have been prepared by the CMBIS solely for the purpose of supplying information to the clients of
CMBIS or its affiliate(s) to whom it is distributed  This report is not and should not be construed as an offer or solicitation to buy or sell any security
or any interest in securities or enter into any transaction  Neither CMBIS nor any of its affiliates shareholders agents consultants directors officers
or employees shall be liable for any loss damage or expense whatsoever whether direct or consequential incurred in relying on the information
contained in this report  Anyone making use of the information contained in this report does so entirely at their own risk
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available
CMBIS provides the information advices and forecasts on an AS IS basis  The information and contents are subject to change without notice
CMBIS may issue other publications having information and or conclusions different from this report  These publications reflect different assumption
andor on behalf of its clients from time to time Investors should assume that CMBIS does or seeks to have investment banking or other business
the objectivity of this report and CMBIS will not assume any responsibility in respect thereof This report is for the use of intended recipients only
and this publication may not be reproduced reprinted sold redistributed or published in whole or in part for any purpose without prior written
consent of CMBIS
For recipients of this document in the United Kingdom
This report has been provided only to persons (I)falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion)
Order 2005 (as amended from time to time)(The Order) or (II) are persons falling within Article 49(2) (a) to (d) (High Net Worth Companies
Unincorporated Associations etc) of the Order and may not be provided to any other person without the prior written consent of CMBIS
For recipients of this document in the United States
This report is intended for distribution in the United States to major US institutional investors as defined in Rule 15a-6 under the US Securities
Exchange Act of 1934 and may not be furnished to any other person in the United States Each major US institutional investor that receives a copy
of this research report by its acceptance hereof represents and agrees that it shall not distribute or provide this research report to any other person
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte Limited (CMBISG) (Company Regn No 201731928D) an Exempt Financial Adviser
as defined in the Financial Advisers Act (Cap 110) of Singapore and regulated by the Monetary Authority of Singapore CMBISG may distribute
reports produced by its respective foreign entities affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of
the Financial Advisers Regulations Where the report is distributed in Singapore to a person who is not an Accredited Investor Expert Investor or
an Institutional Investor as defined in the Securities and Futures Act (Cap 289) of Singapore CMBISG accepts legal responsibility for the contents
of the report to such persons only to the extent required by law Singapore recipients should contact CMBISG at 65 6350 4400 for matters arising
from or in connection with the report